Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | NAAA | Q02083 | 4/20 | 0.38 |
| ▸ | PPM1B | O75688 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5609289 | 0.99 | NAAA (0.40) | EPHX2NAAAEPHX1 | |
| SCHEMBL5608038 | 0.95 | ALDH1A1 (0.38) | EPHX2NAAAPPM1BPTPN1PPP1CC | |
| SCHEMBL5608930 | 0.89 | PPM1B (0.45) | NAAAPPM1BPTPN1PPP1CCMAPT | |
| SCHEMBL5608908 | 0.83 | ALDH1A1 (0.43) | PPM1BPTPN1PPP1CCMAPTNPSR1 | |
| SCHEMBL11187086 | 0.77 | NAAA (0.50) | NAAAEPHX1MAPK1NPSR1 | |
| SCHEMBL2249573 | 0.76 | EPHX2 (0.50) | EPHX2NAAAEPHX1 | |
| SCHEMBL5710073 | 0.74 | NAAA (0.51) | EPHX2NAAAEPHX1 | |
| SCHEMBL1169768 | 0.74 | TSHR (0.49) | EPHX2NAAAEPHX1NPSR1 | |
| SCHEMBL30977763 | 0.74 | NAAA (0.51) | EPHX2NAAAEPHX1 | |
| SCHEMBL21569213 | 0.74 | NAAA (0.51) | EPHX2NAAAEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7169944-B2 | Optically active epoxy compounds and processes for their production | TOSOH CORPORATION (JP) | 2007-01-30 | — | — | US | disclosed |
| US-20040063979-A1 | Optically active epoxy compounds and processes for their production | TOSOH CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1403260-A2 | Optically active epoxy compounds and processes for their production | Tosoh Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063979-A1 | Optically active epoxy compounds and processes for their production | CYP51A1, CYP11B1, PTGES | EPHX2 65/4885NAAA 3511/4885PPM1B 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.